{"id":"W4407238709","doi":"10.1038/s41408-025-01212-0","title":"The clinical journey of belantamab mafodotin in relapsed or refractory multiple myeloma: lessons in drug development","year":2025,"lang":"en","type":"review","venue":"Blood Cancer Journal","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Seagen","keywords":"Medicine; Pomalidomide; Context (archaeology); Clinical trial; Multiple myeloma; Oncology; Internal medicine; Dexamethasone; Daratumumab; Clinical endpoint; Lenalidomide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.003002463,0.0005133279,0.002669586,0.0007359808,0.0002353818,0.00005821763,0.0005978227,0.0003971981,0.0001495317],"category_scores_gemma":[0.00204215,0.0002798288,0.000625623,0.0008130912,0.0001523794,0.00005914558,0.0002116902,0.003344832,0.00001527345],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008774726,"about_ca_system_score_gemma":0.01398101,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002932905,"about_ca_topic_score_gemma":0.00764963,"domain_scores_codex":[0.9937308,0.001172128,0.002907725,0.0004964756,0.0008644149,0.0008284563],"domain_scores_gemma":[0.995051,0.002679277,0.001113235,0.0005109513,0.0002152565,0.0004303084],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0009117957,0.001552647,0.01656853,0.005526442,0.001315471,0.002164361,0.0001524802,6.907772e-7,6.662158e-7,0.00000462859,0.001620388,0.9701819],"study_design_scores_gemma":[0.01597857,0.0003414059,0.02065032,0.08997665,0.001132555,0.0007900961,0.0001557754,0.000005400071,0.00002036719,0.000009825637,0.8706116,0.0003274255],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004539627,0.9926324,0.000001925593,0.0004287533,0.0006016591,0.001351469,0.00006047624,0.00001169332,0.0003719476],"genre_scores_gemma":[0.00173196,0.9928059,0.000698121,0.00003466702,0.0003596591,0.0002768699,0.00003276673,0.0000570069,0.004003032],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9698545,"threshold_uncertainty_score":0.9999654,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1447630802165594,"score_gpt":0.4704130007054941,"score_spread":0.3256499204889347,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}